The Ochsner Journal, 13 (4), 533-540
Low blood sugar is a serious medical condition that can be life-threatening if left untreated
Microdosing discussions focus on something different: whether very small exposures to these medications can influence appetite or metabolic signals without the stronger effects seen at full therapeutic doses
Their model suggests a value-based price of $10,800$16,800 annually depending on patient population and assumptions about diabetes prevention durabilitynotably higher than ICER's 2022 estimate of $9,700, which used more traditional methodology
That could mean an approval before the end of 2021
By improving insulin receptor signalling and promoting glucose metabolism in liver tissues, it helps address a fundamental aspect of NAFLD pathophysiology